Nav: Home

$1 million for intestinal flora research that could potentially prevent obesity

October 04, 2016

The human intestinal tract contains hundreds of different microorganisms and the intestinal flora form a complex society with many billions of cells. Changes and imbalance in the intestinal flora is important for the development of, for example, obesity and diabetes. Therefore, there is great interest in understanding what affects the intestinal flora and how you can change it. Bacteriophages (also called phages) are viruses that attack bacteria (see below).

There is a growing understanding that phages play an important role in the composition of our intestinal flora. The hypothesis of the researchers is that the phages can be actively used to manipulate the composition of the intestinal flora and thus prevent obesity and that a deeper understanding of the phage-bacteria interactions will lead to new, effective ways to control our intestinal flora.

"In the research project PhageGut we will attempt to use lytic phages to shape the composition of the intestinal flora as an alternative to trying to change it through diet, antibiotics or surgery. And we will do it in a way that is very targeted, so we do not affect the intestinal flora's good bacteria," says Associate Professor at the Department of Food Science at the University of Copenhagen, Dennis Sandris Nielsen.

A library of phages and their associated bacterial hosts.

In practical terms, the researchers will isolate the most important phages from the intestinal flora in mice.

"In order to isolate a phage, you have to know which bacteria it attacks. Therefore, we need to get hold of the university's strain collections and also cultivate some of the most important members of the intestinal flora of the mouse," explains Dennis Sandris Nielsen.

The next step is to purify the total population of phages from the intestinal flora in a number of mice. Once this is done, the researchers can put a blanket of phages on top of a blanket of the mouse's intestinal flora bacteria to see where holes arise. A hole (a so-called "plaque") in the blanket of bacteria means that a lytic phage has attacked the bacteria and killed them. When the researchers find a plaque, they can purify the plaque, characterise it and thus determine which phage has attacked which bacterium.

"So we end up with a library of a lot of bacterial hosts and the corresponding phages," says Dennis Sandris Nielsen.

The library of phages is then used to carry out targeted manipulation of the intestinal flora in mice - which are predisposed to develop obesity - in a positive direction.

"Our hypothesis is that we can thus prevent the mice from developing obesity. We will also examine whether phages can be used to introduce health-promoting "probiotic" bacteria into the gut with greater success than is possible today," says Dennis Sandris Nielsen.

Future prospects

If the research with the mice can be transferred to humans, it has the potential for preventing obesity as well as other diseases that seem to be associated with an imbalance in the intestinal flora early in life, including asthma and allergies.

"If you imagine a newborn child with a family history of allergies, obesity or diabetes, it might make sense to screen for certain imbalances in the intestinal flora that may predispose the child to diseases later in life - and here targeted treatment with phages could possibly be used to push the intestinal flora in a positive direction," says Dennis Sandris Nielsen, who emphasises that this is only a potential future scenario.

"We are at a very early stage and we will start by working with mice, which live in a much more uniform environment than humans. But this is certainly a promising project," says Dennis Sandris Nielsen.

Two kinds of phages

Phages (bacteriophages) are viruses that attack bacteria - in this context, bacteria in our intestinal flora. There are two kinds of phages:

The classic lytic phage that attacks by shooting its genetic material into bacteria. It thus takes over the machinery of the bacterium to make new viruses. The bacterial shell that has now been taken over by the phage will explode and send out a lot of new phages into surrounding area, which can then attack new bacteria. The temperate phage also attacks by shooting its genetic material into bacteria. But instead of immediately taking over the bacterium, the phage integrates its genetic material into the bacterial genome. When the bacterium divides, the genetic material of the temperate phage is also shared and a complete copy of its genetic material is passed over into the bacterial daughter cells. This can be beneficial for the bacteria, as the phage protects it from attacks from other phages. As the cell division continues, more and more bacteria will have the phage's DNA. If the bacteria carrying the temperate phages are exposed to different types of stress, the phages can enter into a lytic stage and kill the host bacteria.

PhageGut facts

The Danish Council for Independent Research has awarded 6,293,061 DKK (app 1 million USD) to the PhageGut project, which will run for three years starting on 1 October 2016. The project is led by Associate Professor Dennis Sandris Nielsen, Department of Food Science (FOOD), University of Copenhagen, Denmark. Other participants include Associate Professor Finn Kvist Vogensen and Head of Department Bjarke Bak Christensen from FOOD.

Partners in the project include:

Department of Veterinary Disease Biology, University of Copenhagen, Denmark, Professor Axel Kornerup Hansen

Department of Environmental Science, Aarhus University, Denmark, Professor Lars H. Hansen

Chr. Hansen A/S, Denmark, Head of Department Adam Baker

Université Laval, Canada, Professor Sylvain Moineau

Max-Rubner Institute, Germany, Dr. Charles MAP Franz and Dr. Horst Neve

Universidad de los Andes, Columbia, Ass. Professor Alejandro Reyes

Faculty of Science - University of Copenhagen

Related Diabetes Articles:

The role of vitamin A in diabetes
There has been no known link between diabetes and vitamin A -- until now.
Can continuous glucose monitoring improve diabetes control in patients with type 1 diabetes who inject insulin
Two studies in the Jan. 24/31 issue of JAMA find that use of a sensor implanted under the skin that continuously monitors glucose levels resulted in improved levels in patients with type 1 diabetes who inject insulin multiple times a day, compared to conventional treatment.
Complications of type 2 diabetes affect quality of life, care can lead to diabetes burnout
T2D Lifestyle, a national survey by Health Union of more than 400 individuals experiencing type 2 diabetes (T2D), reveals that patients not only struggle with commonly understood complications, but also numerous lesser known ones that people do not associate with diabetes.
Type 2 diabetes and obesity -- what do we really know?
Social and economic factors have led to a dramatic rise in type 2 diabetes and obesity around the world.
A better way to predict diabetes
An international team of researchers has discovered a simple, accurate new way to predict which women with gestational diabetes will develop type 2 diabetes after delivery.
The Lancet Diabetes & Endocrinology: Older Americans with diabetes living longer without disability, US study shows
Older Americans with diabetes born in the 1940s are living longer and with less disability performing day to day tasks than those born 10 years earlier, according to new research published in The Lancet Diabetes & Endocrinology journal.
Reverse your diabetes -- and you can stay diabetes-free long-term
A new study from Newcastle University, UK, has shown that people who reverse their diabetes and then keep their weight down remain free of diabetes.
New cause of diabetes
Although insulin-producing cells are found in the endocrine tissue of the pancreas, a new mouse study suggests that abnormalities in the exocrine tissue could cause cell non-autonomous effects that promotes diabetes-like symptoms.
The Lancet Diabetes & Endocrinology: Reducing sugar content in sugar-sweetened drinks by 40 percent over 5 years could prevent 1.5 million cases of overweight and obesity in the UK and 300,000 cases of diabetes
A new study published in The Lancet Diabetes & Endocrinology journal suggests that reducing sugar content in sugar sweetened drinks (including fruit juices) in the UK by 40 percent over five years, without replacing them with any artificial sweeteners, could prevent 500,000 cases of overweight and 1 million cases of obesity, in turn preventing around 300,000 cases of type 2 diabetes, over two decades.
Breastfeeding lowers risk of type 2 diabetes following gestational diabetes
Women with gestational diabetes who consistently and continuously breastfeed from the time of giving birth are half as likely to develop type 2 diabetes within two years after delivery, according to a study from Kaiser Permanente published today in Annals of Internal Medicine.

Related Diabetes Reading:

Best Science Podcasts 2019

We have hand picked the best science podcasts for 2019. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Digital Manipulation
Technology has reshaped our lives in amazing ways. But at what cost? This hour, TED speakers reveal how what we see, read, believe — even how we vote — can be manipulated by the technology we use. Guests include journalist Carole Cadwalladr, consumer advocate Finn Myrstad, writer and marketing professor Scott Galloway, behavioral designer Nir Eyal, and computer graphics researcher Doug Roble.
Now Playing: Science for the People

#530 Why Aren't We Dead Yet?
We only notice our immune systems when they aren't working properly, or when they're under attack. How does our immune system understand what bits of us are us, and what bits are invading germs and viruses? How different are human immune systems from the immune systems of other creatures? And is the immune system so often the target of sketchy medical advice? Those questions and more, this week in our conversation with author Idan Ben-Barak about his book "Why Aren't We Dead Yet?: The Survivor’s Guide to the Immune System".